Winthrop Partners - WNY’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$151K Hold
650
0.1% 122
2019
Q2
$152K Hold
650
0.11% 111
2019
Q1
$151K Hold
650
0.12% 106
2018
Q4
$196K Hold
650
0.18% 96
2018
Q3
$230K Hold
650
0.19% 98
2018
Q2
$189K Hold
650
0.16% 103
2018
Q1
$167K Buy
+650
New +$202K 0.13% 128

Other funds holding BIIB

Winthrop Partners - WNY's BIIB Position: Q3 2019 in Review

Winthrop Partners - WNY held its Biogen (BIIB) position steady in Q3 2019 at 650 shares worth $151K. The position accounts for 0.1% of the portfolio, ranked #122.

Winthrop Partners - WNY first reported a position in BIIB in Q1 2018 and has held it in 7 quarters since. The position peaked at $230K in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Winthrop Partners - WNY held 650 shares of Biogen worth $151K as of Q3 2019.
  • Winthrop Partners - WNY left its Biogen share count unchanged in Q3 2019.
  • Biogen made up 0.1% of Winthrop Partners - WNY's portfolio in Q3 2019, its #122 holding.
  • Winthrop Partners - WNY first reported a position in Biogen in Q1 2018 and has held it in 7 quarters since.
  • Winthrop Partners - WNY's Biogen position peaked at $230K in Q3 2018.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.